Stock A377740 BIONOTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioNote, Inc.

Equities

A377740

KR7377740006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
4,125 KRW +0.36% Intraday chart for BioNote, Inc. +1.60% -2.83%
2023 BioNote, Inc.(KOSE:A377740) added to S&P Global BMI Index CI
2023 SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc. CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 874,096 433,228
Enterprise Value (EV) 1 153,997 37,988
P/E ratio 2.63 x -21.1 x
Yield 5.71% 4.71%
Capitalization / Revenue 1.82 x 4.81 x
EV / Revenue 0.32 x 0.42 x
EV / EBITDA 0.51 x -0.98 x
EV / FCF 1,184,919 x -2,031,723 x
FCF Yield 0% -0%
Price to Book 0.55 x 0.28 x
Nbr of stocks (in thousands) 101,876 102,056
Reference price 2 8,580 4,245
Announcement Date 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 40,047 631,505 622,355 479,657 90,081
EBITDA 1 11,338 559,918 474,196 301,861 -38,962
EBIT 1 9,928 558,031 470,090 295,410 -47,168
Operating Margin 24.79% 88.37% 75.53% 61.59% -52.36%
Earnings before Tax (EBT) 1 25,218 695,198 865,667 414,778 -109,491
Net income 1 20,613 528,229 671,556 307,798 -20,497
Net margin 51.47% 83.65% 107.91% 64.17% -22.75%
EPS 2 244.7 5,644 7,178 3,264 -201.0
Free Cash Flow - 150,292 398,869 129,964 -18,697
FCF margin - 23.8% 64.09% 27.1% -20.76%
FCF Conversion (EBITDA) - 26.84% 84.11% 43.05% -
FCF Conversion (Net income) - 28.45% 59.39% 42.22% -
Dividend per Share - 534.0 534.0 490.0 200.0
Announcement Date 3/31/21 3/31/21 3/31/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 4,368 - - - -
Net Cash position 1 - 203,353 487,842 720,100 395,240
Leverage (Debt/EBITDA) 0.3852 x - - - -
Free Cash Flow - 150,292 398,869 129,964 -18,697
ROE (net income / shareholders' equity) - 141% 70.5% 21.4% -1.3%
ROA (Net income/ Total Assets) - 70.9% 25.1% 11.4% -1.76%
Assets 1 - 745,365 2,670,608 2,705,605 1,164,575
Book Value Per Share 2 1,313 6,827 13,536 15,707 15,252
Cash Flow per Share 2 78.10 1,316 4,474 6,685 1,444
Capex 1 1,518 26,698 51,425 42,266 3,963
Capex / Sales 3.79% 4.23% 8.26% 8.81% 4.4%
Announcement Date 3/31/21 3/31/21 3/31/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIONOTE, INC. Stock BioNote, Inc.
-2.83% 305M
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.46% 179B
MEDTRONIC PLC Stock Medtronic plc
-6.43% 98.84B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-7.28% 65.34B
HOYA CORPORATION Stock Hoya Corporation
+15.46% 45.41B
DEXCOM, INC. Stock DexCom, Inc.
-8.93% 44.94B
CENCORA, INC. Stock Cencora, Inc.
+8.19% 43.76B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.00% 29.01B
TERUMO CORPORATION Stock Terumo Corporation
+19.39% 25.65B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-9.09% 23.32B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. A377740 Stock
  4. Financials BioNote, Inc.